Method for screening specific serum metabolism markers for triple-negative breast cancer
A triple-negative breast cancer and metabolic marker technology, applied in the field of biomarkers, can solve the problem that there is no biomarker for screening the metabolic changes of triple-negative breast cancer, and achieve the effect of high sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0030] The present invention will be described in further detail below in conjunction with the accompanying drawings and specific embodiments.
[0031] A method for screening triple-negative breast cancer-specific serum metabolic markers, the method comprising the steps of:
[0032] (1) A number of sera from female patients with triple-negative breast cancer were selected as the experimental group A; normal female sera equal to the number of the experimental group A were selected as the control group B. In this example, the serum of 31 female patients with triple-negative breast cancer was analyzed, and the serum of 31 normal females was used as a control.
[0033] (2) After thawing the serum of experimental group A and control group B at room temperature, accurately pipette 100 μL of serum samples into different 1.5mLEP tubes, use methanol to precipitate protein, and the ratio is sample:methanol=1:4, vortex for 30s, Centrifuge at 12,000 rpm for 15 minutes at 4°C, draw 200 μL...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com